Similar articles

• [Phosphorus and calcium metabolism and the cardiovascular system status in patients with early-stage chronic renal disease].

  Smirnov AV, Volkov MM, Dobronravov VA, Rafrafi H. Smirnov AV, et al. Ter Arkh. 2010;82(6):25-8. Ter Arkh. 2010. PMID: 20731105 Russian.
• [Chronic kidney disease (CKD) and bone. Targets of serum calcium, phosphate, and parathyroid hormone levels and their controls in maintenance dialysis patients].

  Akiba T. Akiba T. Clin Calcium. 2009 Apr;19(4):537-44. Clin Calcium. 2009. PMID: 19329833 Review. Japanese.
• Are CSN and NKF-K/DOQI mineral metabolism guidelines for hemodialysis patients achievable? Results from a provincial renal program.

  Wazny LD, Raymond CB, Lesperance EM, Bernstein KN. Wazny LD, et al. CANNT J. 2008 Apr-Jun;18(2):36-41, 44-50; quiz 42-3, 51-2. CANNT J. 2008. PMID: 18669010 English, French.
• [Parathormone and calcitonin in the blood in chronic kidney diseases].

  Mosin VM, Iagoda AV, Salanda BS, Derevianko NA. Mosin VM, et al. Ter Arkh. 1982;54(7):82-4. Ter Arkh. 1982. PMID: 7135230 Russian. No abstract available.
• Which of the K/DOQI guidelines for bone disease in dialysis patients should be changed?

  Gal-Moscovici A, Sprague SM, Hutchison AJ, Shah N, Piraino B, Cunningham J. Gal-Moscovici A, et al. Semin Dial. 2007 Jan-Feb;20(1):24-32. doi: 10.1111/j.1525-139X.2007.00234.x. Semin Dial. 2007. PMID: 17244115 Review. No abstract available.